Life Sciences and MedTech Payment Performance Slips Slightly: Average Score Dips from 61.1 to 59.8

The Comparison

Here's a snapshot comparing payment practices in the Life Sciences and Medical Technology sectors between 2021 and 2022, based on our analysis:

• 2021: Analysed data from 122 companies in the sector, yielding an average payment performance score of 61.1 out of 100.
• 2022: The study encompassed 109 companies, with the average payment performance score decreasing to 59.8 out of 100.

What This Means

The observed 1.3-point decrease suggests a minor, yet present, weakening in payment performance within the Life Sciences and MedTech industries between 2021 and 2022; this small dip may reflect broader economic pressures impacting operational efficiency within these companies. While the change is not drastic, it warrants attention, and companies should use this late payment calculator to anticipate any potential issues.

One-line summary: Across 122 companies in 2021 and 109 in 2022, the average payment performance score in Life Sciences and MedTech declined from 61.1 to 59.8.